https://pittplusme.org/study/1779
Aptamer Study
We're sorry. This study is closed and no longer recruiting participants.
STUDY BASICS
Are you a healthy, HIV-negative adult? If so, you may be able to participate in a study to help develop a urine test (similar to a urine pregnancy test) designed to measure drug levels of medications used to treat HIV. Researchers hope this test may be able to show if people with HIV infection are taking their medications. This study requires 11 visits over 1 month. Compensation is provided.
IRB: STUDY19100009
- APT-POCT-01: An Open Label, Pharmacokinetic Study of Plasma/Urine/Salivary Drug Concentrations Over Fourteen Days Following Drug Intake Cessation in HIV-Uninfected Healthy Volunteers Dosing to Steady-state to Further Development of Point of Care Diagnosti
AGE:
18 and up
DURATION:
1 month
VISITS:
11
LOCATION:
Magee-Womens Hospital Clinical Translational Research Center (MWH CTRC) - Oakland
COMPENSATION:
Up to $460
SHARE STUDY
MEET THE RESEARCHER
Ken Ho
Ken S. Ho, MD, MPH, is Medical Director at Pitt Men’s Study at the University of Pittsburgh. Dr. Ho’s primary research focuses on biomedical strategies for HIV prevention.